Thameco Pharmaceutical has begun domestic manufacturing of azithromycin as part of Syria’s fight against the COVID pandemic. Dr. Fida Ali, the company’s General Manager, made this exciting announcement in an interview with SANA.
Dr. Ali noted that Thameco has also been authorized by the government to increase production cetamol (acetaminophen), vitamin C, and other essential medications, supplements, and hand sanitizer in quantities required to meet the needs of the population.
Long time readers of Syria News may recognize the name, Thameco Pharmaceutical. It is the largest in Syria and in 2013, the NATO supported FSA terrorists bombed its warehouses in Eastern Ghouta, “to increase the suffering level on the Syrian people.”
Azithromycin is a macrolide that has been successfully used in the treatment of COVID. While it is well known by the layperson that antibiotics cannot cure viruses, the layperson has not been taught that viral and bacterial pathogens engage in cooperation to produce respiratory disease. Obliteration of the pathogenic bacterium helps to weaken the virus.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.